Vanderbilt Center for Arrhythmia Research and Therapeutics, Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Curr Opin Genet Dev. 2022 Dec;77:102004. doi: 10.1016/j.gde.2022.102004. Epub 2022 Nov 9.
Congenital arrhythmia syndromes are rare genetic disorders that can cause a high risk of sudden cardiac death. Expert panels have affirmed 15 genes that are linked to congenital arrhythmias. These genes mostly encode cardiac ion channel proteins or associated regulatory proteins that generate the cardiac action potential. Common genetic variation modulates the risk of rare variants and partially explains the incomplete penetrance of these disorders. As genetic testing becomes more prevalent, a major challenge is that most detected variants are annotated as variants of uncertain significance. This review will highlight emerging methods that are refining our understanding of arrhythmia genetics, including phenotype risk scores, large cohorts, in vitro functional assays, structural models, and computational predictions.
先天性心律失常综合征是罕见的遗传疾病,可导致心脏性猝死的高风险。专家小组已经证实了 15 个与先天性心律失常相关的基因。这些基因主要编码心肌离子通道蛋白或相关调节蛋白,它们产生心肌动作电位。常见的遗传变异调节罕见变异的风险,并部分解释了这些疾病的不完全外显率。随着基因检测的普及,一个主要的挑战是,大多数检测到的变异被注释为意义不明的变异。这篇综述将重点介绍一些新出现的方法,这些方法正在深化我们对心律失常遗传学的理解,包括表型风险评分、大样本队列、体外功能测定、结构模型和计算预测。